Lv32
388 积分 2024-09-12 加入
A Monoclonal Antibody to PACAP for Migraine Prevention
1天前
已完结
Neurovascular Complications of Iatrogenic Fusarium solani Meningitis
8天前
已完结
BHV-2100, a First-in-class TRPM3 Antagonist for the Treatment of Pain (S13.002)
11天前
已关闭
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
24天前
已完结
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer
24天前
已完结
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
30天前
已完结
Structural insight into selectivity of amylin and calcitonin receptor agonists
1个月前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
1个月前
已完结
An Updated Review on Glycoprotein IIb/IIIa Inhibitors as Antiplatelet Agents: Basic and Clinical Perspectives
1个月前
已完结
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
1个月前
已完结
皖公网安备34019202002308
